Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews

No studies found 1 · 16.7%GRADE not reported 0 · 0%Very low 2 · 33.3%Low 3 · 50%Moderate 0 · 0%High 0 · 0%

Adverse events · people with surgically‐induced remission in Crohn's disease

5‐ASAs showed no clear difference in adverse events compared with placebo (low certainty).

1 finding from 1 review

Adverse events · people with surgically‐induced remission in Crohn's disease

It is very uncertain whether 5‐ASAs changes adverse events compared with anti TNF‐ɑ (very low certainty).

1 finding from 1 review

Serious adverse events · people with surgically‐induced remission in Crohn's disease

5‐ASAs showed no clear difference in serious adverse events compared with placebo (low certainty).

1 finding from 1 review

Serious adverse events · people with surgically‐induced remission in Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to adverse events · people with surgically‐induced remission in Crohn's disease

5‐ASAs showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).

1 finding from 1 review

Withdrawals due to adverse events · people with surgically‐induced remission in Crohn's disease

It is very uncertain whether 5‐ASAs changes withdrawal due to adverse events compared with anti TNF‐ɑ (very low certainty).

1 finding from 1 review